Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

National shortage of purified-protein derivative tuberculin products.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Apr 26;62(16):312.

PMID:
23615675
[PubMed - indexed for MEDLINE]
Free Article
2.

Extent and effects of recurrent shortages of purified-protein derivative tuberculin skin test antigen solutions - United States, 2013.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 Dec 13;62(49):1014-5.

PMID:
24336135
[PubMed - indexed for MEDLINE]
Free Article
3.

Increase in tuberculin skin test converters among health care workers after a change from Tubersol to Aplisol.

Gillenwater KA, Sapp SC, Pearce K, Siberry GK.

Am J Infect Control. 2006 Dec;34(10):651-4.

PMID:
17161740
[PubMed - indexed for MEDLINE]
4.

[Future supply of tuberculin in Germany].

Sagebiel D, Hauer B, Haas W, Magdorf K, Priwitzer M, Loddenkemper R.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2005 Apr;48(4):477-82. German.

PMID:
15830261
[PubMed - indexed for MEDLINE]
5.

Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis.

Duchin JS, Jereb JA, Nolan CM, Smith P, Onorato IM.

Clin Infect Dis. 1997 Sep;25(3):661-3.

PMID:
9314456
[PubMed - indexed for MEDLINE]
Free Article
6.

Comparing interferon- gamma release assay with tuberculin skin test readings at 48-72 hours and 144-168 hours with use of 2 commercial reagents.

Tat D, Polenakovik H, Herchline T.

Clin Infect Dis. 2005 Jan 15;40(2):246-50. Epub 2004 Dec 17.

PMID:
15655742
[PubMed - indexed for MEDLINE]
Free Article
7.

Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.

Villarino ME, Burman W, Wang YC, Lundergan L, Catanzaro A, Bock N, Jones C, Nolan C.

JAMA. 1999 Jan 13;281(2):169-71.

PMID:
9917121
[PubMed - indexed for MEDLINE]
8.

Simultaneous comparison of reactivity to purified protein derivative RT-23 and Tubersol in health care workers in Vitória, Brazil.

Teixeira L, Maciel E, Dutra ME, Perkins MD, Johnson JL, do Valle Dettoni V.

Int J Tuberc Lung Dis. 2000 Nov;4(11):1074-7.

PMID:
11092721
[PubMed - indexed for MEDLINE]
9.

Differences in tuberculin reactivity as determined in a veterans administration employee health screening program.

Mehta SR, MacGruder C, Looney D, Johns S, Smith DM.

Clin Vaccine Immunol. 2009 Apr;16(4):541-3. doi: 10.1128/CVI.00375-08. Epub 2009 Feb 18.

PMID:
19225075
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

False-positive tuberculin skin tests in a state prison system.

Grabau JC, Hughes SE, Foster EA, Kearns CH, Klopf L.

Int J Tuberc Lung Dis. 2003 Jan;7(1):93-7.

PMID:
12701841
[PubMed - indexed for MEDLINE]
11.
12.

Purified protein derivatives of tuberculin--past, present, and future.

Yang H, Kruh-Garcia NA, Dobos KM.

FEMS Immunol Med Microbiol. 2012 Dec;66(3):273-80. doi: 10.1111/j.1574-695X.2012.01002.x. Epub 2012 Aug 1. Review.

PMID:
22762692
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Tuberculin testing in a tertiary hospital: product variability.

Shands JW Jr, Boeff D, Fauerbach L, Gutekunst RR.

Infect Control Hosp Epidemiol. 1994 Dec;15(12):758-60.

PMID:
7890924
[PubMed - indexed for MEDLINE]
14.

Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States.

von Reyn CF, Horsburgh CR, Olivier KN, Barnes PF, Waddell R, Warren C, Tvaroha S, Jaeger AS, Lein AD, Alexander LN, Weber DJ, Tosteson AN.

Int J Tuberc Lung Dis. 2001 Dec;5(12):1122-8.

PMID:
11769770
[PubMed - indexed for MEDLINE]
15.

Evaluation of the sensitivity of RT-23 purified protein derivative for determining tuberculin reactivity in a group of health care workers.

Molina-Gamboa JD, Ponce-de-León-Rosales S, Rivera-Morales I, Romero C, Báez R, Huertas M, Osornio G.

Clin Infect Dis. 1994 Oct;19(4):784-6.

PMID:
7803652
[PubMed - indexed for MEDLINE]
16.

Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.

Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A; Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2005 Dec 16;54(RR-15):49-55. Erratum in: MMWR Morb Mortal Wkly Rep. 2005 Dec 23;54(50):1288.

PMID:
16357824
[PubMed - indexed for MEDLINE]
Free Article
17.

Utility of dual skin tests to evaluate tuberculin skin test reactions of 10 to 14 mm in healthcare workers.

Marsh BJ, San Vicente J, von Reyn CF.

Infect Control Hosp Epidemiol. 2003 Nov;24(11):821-4.

PMID:
14649769
[PubMed - indexed for MEDLINE]
18.

CDC clarifies when to retest staff shown positive by Aplisol TB test.

[No authors listed]

Hosp Employee Health. 1982 Dec;1(12):160-2. No abstract available.

PMID:
10313973
[PubMed - indexed for MEDLINE]
19.

Tuberculosis in physicians: compliance with surveillance and treatment.

Ramphal-Naley L, Kirkhorn S, Lohman WH, Zelterman D.

Am J Infect Control. 1996 Aug;24(4):243-53.

PMID:
8870908
[PubMed - indexed for MEDLINE]
20.

Tuberculosis and tuberculin quality: best intentions, misleading results.

Rangel-Frausto MS, Ponce-De-León-Rosales S, Martinez-Abaroa C, Hasløv K.

Infect Control Hosp Epidemiol. 2001 Aug;22(8):481-4.

PMID:
11700874
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk